A study to find out if 3 injections with a vaccine (given over the course of 30 days) to prevent infection with Clostridium difficile (C difficile) is safe and well tolerated in healthy people who were 50 to 85 years of age

A Phase 2, placebo-controlled, randomized, observer-blinded trial to evaluate the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered as a 3-dose regimen in healthy adults aged 50 to 85 years

Category & Conditions:
Vaccine-related Conditions
Medicine:
PF-06425090
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B5091003
Open Plain Language Summary Result:Click here